Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qlaira versus Microgynon-30 thrombogenicity study
NL-OMON35104Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of estradiol valerate + dienogest and ethinylestradiol + levonorgestrel in contraception (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Thrombin generation based APC resistance and Sex hormone-binding globulin. Started May 2010; status: active, not recruiting.
02
Drugs
estradiol valerate + dienogestethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON35104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35104.